Morgan Stanley’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
VCM
VFT
PP
XT
VF
Morgan Stanley's BCDA Position: Q1 2026 in Review
Morgan Stanley held its BioCardia (BCDA) position steady in Q1 2026 at 3,105 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #7208.
Morgan Stanley first reported a position in BCDA in Q3 2019 and has held it in 27 quarters since. The position peaked at $8.76K in Q4 2024. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.
- Morgan Stanley held 3,105 shares of BioCardia worth $3.76K as of Q1 2026.
- Morgan Stanley left its BioCardia share count unchanged in Q1 2026.
- BioCardia made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7208 holding.
- Morgan Stanley first reported a position in BioCardia in Q3 2019 and has held it in 27 quarters since.
- Morgan Stanley's BioCardia position peaked at $8.76K in Q4 2024.
- 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.